Clinical Trials for La Jolla Pharmaceutical

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: La Jolla Pharmaceutical

Clinical Trials (3)

NCT06122987
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
PHASE4Recruiting
50 participants
Started: Dec 4, 2023 · Completed: Jan 31, 2025
4 conditions2 sponsors1 location
NCT04901169
Angiotensin II in Liver Transplantation
PHASE2/PHASE3Recruiting
50 participants
Started: Jun 28, 2022 · Completed: Sep 1, 2026
2 conditions2 sponsors1 location
NCT04904562
Angiotensin II for Distributive Shock
PHASE4Recruiting
40 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location